Cancer is one of the great challenges of humanity in the 21st century. I don't think there is a single person on the face of the Earth who have not suffered directly or indirectly from this disease. We've all had at one time a relative who died because of it.

In the United States the cancer is one of the leading causes of death. Statistics show terrifying figures: more than 1500 people die daily in the U.S. alone because of this disease. Also, cancer is the second most prevalent disease after cardiac affections.

According to the researchers in the field of medicine in Manchester, United Kingdomhave created a new type of therapy to fight the disease.

It is a therapy based on microscopic "grenade", supplied with heat. These grenades have the ability to explode at the level of body tumors.According to them, the new therapy would be more effective than standard treatments. Standard treatments involve a poisoning of the whole body hoping that cancerous tumors will be damaged. Such treatments destroy everything including the individual's immune system. New therapy based on these microscopic ”grenades” avoid this mass destruction.

The therapy uses small fat bubbles carrying different substances in the body — to release drugs with toxic role against tumors, when their temperature begins to rise. . Oncologists have wished to make use of the skills of these spheres of fat, causing them to carry through the bodyvarious toxic drugs directly where the tumor is located without hurting other parts of the body.

Studies on mice suffering from melanoma have shown very good results. Most of them have presented signs of improvement, and the survival rate was very high.Kostas Kostarelos, researcher at the University of Manchester and at the same time the leader of the study group considered this discovery as a new age in Oncology. These facts come to the context in which the World Health Organization ( W.H.O.) has predicted that in 2030 the number of deaths caused by cancer will reach approximately 13.2 million annually, almost double the level of 2008.